Women's Health News

RSS

Advocates lobbying for passage of International Violence Against Women Act

"Supporters of the International Violence Against Women Act (I-VAWA) are ramping up their lobbying efforts as Congress prepares to bring the measure to a vote," The Hill reports. More than a dozen organizations and advocacy groups have written a letter requesting the support of Sen. George Voinovich, R-Ohio. The bill currently has two Republican sponsors in the senate and "advocates say his support will be vital to obtaining the desired amount of funding from Congress: up to $1.3 billion over five years," the newspaper writes.

14 Jul 2010

Obama Administration approves direct federal funding of abortion: FRC Action

Family Research Council Action responded today to a discovery made by the National Right to Life Committee that the Obama Administration has given federal approval to send Pennsylvania $160 million in taxpayer funds which will directly fund abortions through President Obama's recently enacted health care law.

14 Jul 2010

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit. This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.

13 Jul 2010

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women

BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.

13 Jul 2010

Women with gestational diabetes during first, second pregnancies at increased risk of recurrence

There is an increased risk of recurring gestational diabetes in pregnant women who developed gestational diabetes during their first and second pregnancies, according to a Kaiser Permanente study appearing online in The American Journal of Obstetrics and Gynecology.

13 Jul 2010

QIAGEN's digene HPV Test improves cervical cancer control: Study

A study released today "online first" in Cancer Causes & Control demonstrates that human papillomavirus testing, using QIAGEN's digene HPV Test, improved cervical cancer control compared to routine Pap (cytology) testing among 50,000 women across Mexico, the first country in Latin America to implement a national screening program for the high-risk types of HPV that can cause cervical cancer.

From QIAGEN Manchester Limited 13 Jul 2010

High fat diet while nursing poses greater risk for infant obesity

The future health of offspring is more negatively impacted when their mothers consume a high fat diet while nursing compared with high-fat diet consumption during pregnancy, according to animal research at Johns Hopkins University. These new research results are being presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior.

13 Jul 2010

New study shows SAVI radiation therapy controls rate of breast cancer

A new study of breast cancer patients at the Moores UCSD Cancer Center and the Arizona Oncology Services shows that after almost two years, the radiation given with the Strut-Adjusted Volume Implant controls the rate of cancer and may reduce the complications seen with alternate types of brachytherapy.

13 Jul 2010

Intensive weight loss intervention program reduces hot flushes in overweight, obese women

Among overweight and obese women with bothersome hot flushes during menopause, an intensive weight loss intervention program may lead to improvements in flushing, according to a report in the July 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Jul 2010

Soy reduces weight gain in post-menopausal female rats

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, finds that a diet rich in soy prevents weight gain in post-menopausal female rats.

13 Jul 2010

FRC refutes RCOG claims on fetal pain

The Family Research Council today released a new report that refutes claims made recently by the Royal College of Obstetricians and Gynaecologists' (RCOG) that a fetus is not able to feel pain before 24 weeks of development. RCOG's study is being used to uphold Britain's current legalization of abortions up to 24 weeks.

13 Jul 2010

Weight loss related to fewer hot flashes in menopausal women: study

Hot flashes are an uncomfortable and distressing part of menopause that many women go through. Hot flashes also known as hot flushes are usually sudden sweatiness and redness in the face that can remain for four or five years into menopause. Now researchers have shown that losing weight may help reduce these symptoms.

13 Jul 2010

Marking World Population Day, U.N. points to relationship between population growth, MDGs

U.N. officials marked World Population Day on Sunday, highlighting the relationship between population trends and the successful implementation of the Millennium Development Goals, Xinhua reports.

13 Jul 2010

IDSI installs CT Laser Mammography system at Tata Memorial Hospital

Imaging Diagnostic Systems, Inc., a pioneer in laser optical breast imaging, announced today that it has installed the first CT Laser Mammography (CTLM) system at Tata Memorial Hospital, the national comprehensive cancer centre in Mumbai, India.

12 Jul 2010

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

Asthma is the most common complication of pregnancy in Australia with harmful effects on babies, but many of these could be prevented a University of Adelaide researcher says.

12 Jul 2010

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Novelos Therapeutics, Inc., a biopharmaceutical company developing therapeutics to treat cancer and hepatitis, today announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine.

12 Jul 2010

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

Devicor Medical Products, Inc., a portfolio company of GTCR, announced today that the company has completed the acquisition of Ethicon Endo-Surgery's (EES) Breast Care business. The Breast Care business sells products designed to help doctors diagnose breast cancer at early stages while minimizing patient discomfort. The business will formally be known as Mammotome, a division of Devicor Medical Products, Inc.

12 Jul 2010

MiCK assay effective in predicting best chemotherapy response for Endometrial Cancer patients: Study

Oncologists working with DiaTech Oncology have published the results of a comprehensive study to determine the effectiveness of the Microculture Kinetic (MiCK) assay for apoptosis in predicting the best chemotherapy response for Endometrial Cancer patients. (Journal of Gynecologic Oncology March 2010 Mar)

12 Jul 2010

Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research

Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that a manuscript based on a study of Clarient InsightDx Mammostrat, a test used to classify the risk of recurrence of breast cancer following surgery and chemotherapy, will be published in an upcoming edition of Breast Cancer Research, a prominent peer-reviewed medical journal.

12 Jul 2010

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

Vaccine manufacturers in India and other developing countries may be able to produce a lower-cost HPV vaccine in spite of the complicated array of patent protections on the technology, say researchers at the Duke Institute for Genome Sciences & Policy. At a cost of at least $300 for the three-dose regimen, the blockbuster HPV vaccines, including Gardasil- from Merck and Cervarix- from GlaxoSmithKline, are some of the most expensive ever introduced.

12 Jul 2010

Women's Health News

Advocates lobbying for passage of International Violence Against Women Act

Obama Administration approves direct federal funding of abortion: FRC Action

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women

Women with gestational diabetes during first, second pregnancies at increased risk of recurrence

QIAGEN's digene HPV Test improves cervical cancer control: Study

High fat diet while nursing poses greater risk for infant obesity

New study shows SAVI radiation therapy controls rate of breast cancer

Intensive weight loss intervention program reduces hot flushes in overweight, obese women

Soy reduces weight gain in post-menopausal female rats

FRC refutes RCOG claims on fetal pain

Weight loss related to fewer hot flashes in menopausal women: study

Marking World Population Day, U.N. points to relationship between population growth, MDGs

IDSI installs CT Laser Mammography system at Tata Memorial Hospital

Proper management of asthma during pregnancy reduces risk of harmful effects on babies

Novelos reports positive results from NOV-002 Phase 2 neoadjuvant breast cancer trial

Devicor completes acquisition of Ethicon Endo-Surgery's Breast Care business

MiCK assay effective in predicting best chemotherapy response for Endometrial Cancer patients: Study

Manuscript based on study of Clarient InsightDx Mammostrat to be published in Breast Cancer Research

Vaccine manufacturers may be able to produce lower-cost HPV vaccines, say researchers

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News